ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

PYXS Pyxis Oncology Inc

3,59
-0,07 (-1,91%)
19 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Pyxis Oncology Inc PYXS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,07 -1,91% 3,59 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,70 3,40 3,70 3,42 3,66
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
12.6.202422:17EDGAR2Form 8-K - Current report
10.6.202413:56EDGAR2Form 8-K - Current report
10.6.202413:30GLOBEPyxis Oncology Expands Board of Directors with Appointment..
07.6.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.5.202413:30GLOBEPyxis Oncology to Participate in a Fireside Chat at the..
14.5.202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.5.202413:55EDGAR2Form 8-K - Current report
14.5.202413:30GLOBEPyxis Oncology Provides Corporate Update and Reports..
09.5.202413:30GLOBEPyxis Oncology to Present at the RBC Capital Markets Global..
28.3.202421:30GLOBEPyxis Oncology Reports Inducement Grants Under Nasdaq..
27.3.202412:30GLOBEPyxis Oncology Obtains $8 Million Payment for the Sale of..
21.3.202412:30GLOBEPyxis Oncology Provides Corporate Update and Reports..
13.3.202413:00GLOBEPyxis Oncology Expands Board of Directors with Appointment..
08.3.202422:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07.3.202422:30GLOBEPyxis Oncology to Present at Leerink Global Biopharma..
05.3.202422:45GLOBEPyxis Oncology to Present New PYX-201, PYX-106 and PYX-102..
28.2.202413:02EDGAR2Form 8-K - Current report
27.2.202414:00GLOBEPyxis Oncology Announces $50 Million Private Placement
29.12.202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202322:30GLOBEPyxis Oncology Reports Inducement Grants Under Nasdaq..
06.12.202322:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
30.11.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202313:22EDGAR2Form 8-K - Current report
28.11.202313:00GLOBEPyxis Oncology Announces Appointment of Ken Kobayashi, M.D.,..
17.11.202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.11.202322:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:44EDGAR2Form 8-K - Current report
07.11.202322:30GLOBEPyxis Oncology Announces Initiatives to Prioritize Lead ADC..
27.10.202322:34EDGAR2Form 8-K/A - Current report: [Amend]
28.9.202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.9.202300:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.9.202300:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.9.202315:18GLOBEPyxis Oncology Announces Four Abstracts Accepted for Poster..
25.9.202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.9.202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.9.202301:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.9.202301:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202323:08EDGAR2Form 144 - Report of proposed sale of securities
31.8.202322:01GLOBEPyxis Oncology to Participate in Two Upcoming Investment..
25.8.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
23.8.202323:30EDGAR2Form S-8 POS - Securities to be offered to employees in..
23.8.202323:28EDGAR2Form POS AM - Post-Effective amendments for registration..
23.8.202323:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
23.8.202314:47EDGAR2Form 8-K - Current report
23.8.202314:35GLOBEPyxis Oncology Successfully Completes Acquisition of..
11.8.202323:00EDGAR2Form 144 - Report of proposed sale of securities
11.8.202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11.8.202313:26EDGAR2Form 425 - Prospectuses and communications, business..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock